SynthesisMedicine2016

Angiotensin II Receptor Blockers and Cancer Risk: A Meta-Analysis of Randomized Controlled Trials.

Yun-Tao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.